Home Podcasts Pharma Talks
Pharma Talks

Pharma Talks

Nataliya Andreychuk 35 episodes Latest Jun 5, 2026

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions.

Episodes

Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Lauren Leahy Jun 5, 2026 194 In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today.Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices.Key takeaways:AI isn't elimi
Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Laetitia Huret Jun 4, 2026 358 In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground.Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space.Key
Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 2 Jun 3, 2026 1140 Watch the first part of the conversation: https://youtu.be/PtR62juQ4FYThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRCO
Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 1 May 26, 2026 1187 Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRC
Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Vanitha Venkatasubramaniam May 11, 2026 185 In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead.Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the
Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Maryna Alexeychuk May 5, 2026 285 In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.Key takeaways
Pharma Talks Live from Reuters Pharma Barcelona with Marc Koolen May 4, 2026 269 In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.link
Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Haider Alleg May 2, 2026 371 In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and m
Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Yacin Marzouki Apr 30, 2026 283 In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.Key takeaways:- AI in pharma marketing requires systemic thinking, not point solutions- Content without
HCP Engagement in Pharma — Are We Actually Getting Better? l Pharma Talks with Nataliya Andreychuk Apr 22, 2026 1922 Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means at the behaviour level.Key Topics:The ga
Pharma Talks Live from Philadelphia | AI, Omnichannel & Market Access Disruption Apr 7, 2026 1793 In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.👥 Guests in this episode:Rohit Khuttan — Practice Director, Everest GroupOn AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset i
Pharma Talks: Building Trust in Agentic AI in Pharma Mar 27, 2026 816 In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity.Takeaways:Trust in agentic AI and safety measures in pharmaThe importance of women in AI development and diversityTechnical approaches to secure and reliabl

Recommended

Playing